tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gobind Singh, 17 are a BUY (94.44%), 1 are a HOLD (5.56%).
Analyst Gobind Singh, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 40% that have a potential upside of 37.04% achieved within 139 days.
Gobind Singh’s has documented 35 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RPHM, Reneo Pharmaceuticals at 08-Sep-2023.
Analyst best performing recommendations are on RPHM (RENEO PHARMACEUTICALS).
The best stock recommendation documented was for RPHM (RENEO PHARMACEUTICALS) at 9/19/2022. The price target of $31 was fulfilled within 8 days with a profit of $9.8 (24.02%) receiving and performance score of 30.02.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$2
$1.95 (3900.00%)
$80
1 years 7 months 6 days ago
(26-Jul-2023)
1/2 (50%)
$-5.88 (-74.62%)
83
Buy
$10
$9.96 (24900.00%)
$10
1 years 11 months 15 days ago
(17-Mar-2023)
2/2 (100%)
$4.82 (93.05%)
79
Buy
$5
$4.96 (12400.00%)
1 years 11 months 16 days ago
(16-Mar-2023)
1/1 (100%)
$-0.98 (-16.39%)
4
Buy
$280
2 years 1 months 3 days ago
(01-Feb-2023)
1/3 (33.33%)
$120.6 (75.66%)
6
Buy
$50
$49.95 (99900.00%)
$12
2 years 3 months 16 days ago
(16-Nov-2022)
3/4 (75%)
$4.2 (9.17%)
100
What Year was the first public recommendation made by Gobind Singh?
